A Lection in Humbleness: Crystallization of Chiral and Zwitterionic APIs Baclofen and Phenibut

Crystallization and multicomponent crystal formation of active pharmaceutical ingredients Baclofen and Phenibut with dicarboxylic acid co-formers are discussed. The crystallization process of several crystalline entities is elucidated via single crystal-as well as powder X-ray-diffraction, followed by thermal analysis and phase stability studies over time. Both APIs form increasingly complex crystalline phases with co-formers malic and tartaric acid, where phase purity of a desired compound is not necessarily a given. Therefore, the influence of different solution and milling environments during crystallization on the outcome is studied. Emphasis is laid on how molecular influences such as the chirality, propensity to form hydrates as well as low solubility of Baclofen and Phenibut impede attempts to gather high-quality single crystals. The results highlight that targeted crystallization of these compounds with dicarboxylic acids can be difficult and unreliable.

Automated summary

This study discusses the crystallization and multicomponent crystal formation of active pharmaceutical ingredients with dicarboxylic acid co-formers. The research elucidates the crystallization process of several crystalline entities and investigates the factors influencing the outcome.